In order to control weeds in rice in Asia, FMC Corporation and Syngenta Crop Protection have entered into a partnership. Tetflupyrolimet, the…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
BASF
BASF Launches Diadem(Mefentrifluconazole 100 g/l+ Fluxapyroxad 50 g/l) Fungicide to Protect Sugar Beet in Germany
by adminby adminDiadem, a highly efficient new fungicide from BASF, not only provides thorough and dependable disease protection but also enables active resistance management…
-
Summary :- Revysol® is the first Isopropanol-Azole in the market. Its unique chemical constellation allows the molecule to assume different conformations easily and to…
-
Corteva
Corteva Agriscience launches Adavelt™ Active(florylpicoxamid) New Fungicide
by adminby adminCorteva Agriscience announced the commercial launch of Adavelt™ active, with recent product registrations in three countries – Australia, Canada and South Korea.…
-
AgrochemicalsCorteva
Corteva Agriscience Announces Commercial Launch of Vorceed™ Enlist®(Glyphosate, Glufosinate, 2,4-D choline and FOP)for Corn productsL
by adminby adminCorteva Agriscience today announced plans for the commercial launch of Vorceed™ Enlist® corn products. U.S. farmers will access Vorceed Enlist corn technology…
-
Adama
ADAMA Canada to Offer new Herbicide DAVAI A Plus (Imazamox +Clethodim)for Imi-tolerant lentils, as well as Peas and Soybeans
by adminby adminSummary:- DAVAI A PLUS™ combines 2 actives Imazamox ,Clethodim to tackle broadleaf and grassy weeds. DAVAI A Plus, a new pulse crop…
-
GileadRegulatoryU.S FDA
Sunlenca® (lenacapavir) Receives FDA Approval as a First-in-Class, Twice-Yearly Treatment Option for People Living With Multi-Drug Resistant HIV
by adminby adminSummary :- Sunlenca is the First and Only Approved Capsid Inhibitor-Based HIV Treatment Option New Drug Application Approval Based on High Rates…
-
GskPharma Science & Research
GSK and Wave Life Sciences Establish a Partnership to further the Identification and Development of Therapeutic Oligonucleotides that Target Novel Genomic Targets.
by adminby adminGSK plc (LSE/NYSE: GSK) and Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for…
-
Mirati TherapeuticsRegulatoryU.S FDA
Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation
by adminby adminSummary :-Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted…
-
CompaniesPfizerRegulatoryU.S FDA
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma
by adminby adminPfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…
Newer Posts